(-)-CP 55,940 |
| カタログ番号GC18343 |
(-)-CP 55,940は、CB1受容体とCB2受容体に対してKi値がそれぞれ0.5〜5および0.69〜2.8 nMである、強力かつ非選択的なカンナビノイド（CB）受容体アゴニストです。
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 83002-04-4
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
(-)-CP 55,940 is a potent and non-selective cannabinoid (CB) receptor agonist with Ki values of 0.5 to 5 and 0.69 to 2.8 nM for CB1 and CB2 receptors, respectively. It is more potent than Δ9-THC - in both behavioral tests and in receptor binding assays. In vivo, (-)-CP 55,940 administered intraperitoneally (0.3-3 mg/kg) or as an aerosol (0.72-72 mg/ml), suppresses locomotor activity, increases tail flick latency in a hot plate test for analgesia, and decreases body temperature in mice in a dose-dependent manner. Subchronic administration of (-)-CP 55,940 (0.03 mg/kg) also reduces body weight loss and running wheel activity in a rat model of anorexia nervosa.
Review for (-)-CP 55,940
Average Rating: 5 (Based on Reviews and 11 reference(s) in Google Scholar.)
Review for (-)-CP 55,940
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *